You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Alexion

Alexion Pharmaceuticals

121 Seaport Blvd
Boston, MA 02210

alexion.com
hypophosphatasia.com
strensiq.com

Chris Melton
chris.melton@alexion.com
360-303-5630

Who We Are

Alexion is a global biopharmaceutical company focused on serving patients and families affected with rare diseases through the discovery, development and commercialization of life-changing therapies.

People living with rare and devastating diseases are our Guiding Star. We believe it is our responsibility to listen to, understand, and change the lives of patients and those who work tirelessly to help them. Our mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovation and creating meaningful value in all that we do.

Alexion has 5 approved therapies treating 7 rare diseases and devastating conditions in 50 countries.